Rhode Island's S 2203 is the fifth state genetic privacy law enacted this year, with enforcement authority resting solely with the Attorney General. Civil penalties range from $1,000 for negligent violations to $10,000 for willful ones. Yet many compliance teams still treat genetic data like any other personal information. That's the first mistake.
Why These Mistakes Keep Happening
Genetic privacy intersects healthcare, consumer products, and data protection. Your team might have HIPAA expertise or General Data Protection Regulation knowledge, but genetic testing companies don't fit neatly into either category. Direct-to-consumer genetic testing operates outside HIPAA's framework. State laws like S 2203 create obligations resembling privacy regulations but use enforcement mechanisms from consumer protection statutes.
The patchwork nature adds to the challenge. With five states enacting genetic privacy laws this year alone, you're managing overlapping requirements with varying definitions, consent standards, and breach notification triggers. Most compliance programs weren't designed for this rapid state-level regulatory change.
Mistake 1: Treating Genetic Data as "Just Sensitive PII"
Your data classification likely labels genetic information as sensitive personal data, applies standard encryption and access controls, and considers it done. But genetic data carries unique risks that standard PII protections don't address.
Genetic information reveals health predispositions not just for the individual but for blood relatives who never consented to testing. It's immutable. You can't issue someone a new genome like a new credit card after a breach. The privacy harm extends across generations and can't be remediated through traditional means.
The fix: Create a separate data category for genetic information with heightened controls. Your Data Subject Access Request process needs specific workflows for genetic data that consider familial privacy implications. When someone requests deletion of genetic data, you need documented procedures that address derivative data products like health risk assessments or ancestry reports generated from the original sample. Standard "delete the record" procedures don't capture this complexity.
Mistake 2: Assuming Your Consent Language Covers New State Requirements
You probably updated your privacy notice when the General Data Protection Regulation took effect, added California Consumer Privacy Act disclosures, and assumed your consent framework was comprehensive. Then S 2203 and similar state laws introduced requirements your existing consent doesn't satisfy.
These genetic privacy statutes often mandate specific disclosures about data sharing, require separate consent for marketing uses, and impose restrictions on law enforcement access that exceed what your current privacy notice addresses. Your blanket "we may share with third parties for business purposes" language won't suffice.
The fix: Map each state's genetic privacy requirements against your current consent language. Rhode Island's S 2203 requires explicit consent for genetic data collection and processing. You need granular consent mechanisms that let users approve or deny specific uses: research participation, third-party sharing, marketing, law enforcement requests. This isn't a privacy notice update; it's a consent architecture redesign. Your Consent Management Platform needs to track state-specific genetic data consents separately and apply the most restrictive standard when user location is uncertain.
Mistake 3: Overlooking the "Direct-to-Consumer" Trigger
Your legal team might've reviewed genetic privacy laws and concluded they don't apply because you're not a genetic testing company. But these statutes often define "direct-to-consumer genetic testing company" broadly enough to capture unexpected businesses.
If you're a wellness platform that partners with a lab to offer genetic testing as part of a premium membership, you might fall under the definition. If you're a research institution that returns individual results to study participants, the line between research and DTC service blurs. If you acquire a company that once offered genetic testing, even if you've discontinued the service, you still possess genetic data subject to these laws.
The fix: Conduct a genetic data inventory across your entire organization, including acquired entities and partnership arrangements. Document the original collection purpose, current use, and retention period for every genetic dataset you hold. For each state where you have users or data subjects, determine whether your activities meet that state's definition of DTC genetic testing. Don't rely solely on self-assessment; get outside counsel to review borderline cases. The penalties for getting this wrong include both civil fines and potential consumer lawsuits.
Mistake 4: Ignoring the Enforcement Model
You're used to privacy regulations enforced by data protection authorities with rulemaking power and structured investigation processes. Genetic privacy laws often hand enforcement to state Attorneys General operating under consumer protection statutes. The enforcement approach differs fundamentally.
AGs pursue cases that generate headlines and demonstrate consumer protection wins. They're less interested in your compliance documentation and more focused on consumer harm narratives. A single sympathetic plaintiff with a compelling story can trigger an investigation faster than a systematic audit finding. The Rhode Island Attorney General's exclusive enforcement authority under S 2203 means there's no regulatory agency to issue guidance, no safe harbor provisions, and no advance ruling process.
The fix: Build your genetic privacy compliance program with AG enforcement in mind. Document not just what controls you've implemented, but the consumer protection rationale behind each decision. When designing data retention policies, think about how you'd explain a five-year retention period to a prosecutor, not just an auditor. Establish a rapid response protocol for AG inquiries that doesn't rely on the 30-day response windows common in privacy regulations. Train your customer service team to escalate genetic data complaints immediately; an AG investigation often starts with consumer complaints that your support team mishandled.
Mistake 5: Building State-by-State Point Solutions
As each new state enacts genetic privacy legislation, your instinct might be to create state-specific compliance procedures. Rhode Island gets a Rhode Island playbook, Utah gets a Utah playbook. This approach breaks down quickly when you're operating in multiple states with overlapping but non-identical requirements.
You'll end up with consent flows that vary by user location, data retention schedules that depend on which state law applies, and breach notification procedures that require legal review every time an incident occurs. Your engineering team will push back on implementing location-based business logic for every state-specific requirement.
The fix: Identify the highest common denominator across all state genetic privacy laws and build your baseline controls to that standard. If one state requires explicit consent for marketing and another allows opt-out, implement explicit consent everywhere. If one state mandates 30-day breach notification and another allows 60 days, notify within 30 days regardless of jurisdiction.
This approach costs more upfront but scales as new states enact laws. You're not retrofitting your consent management system every quarter. Document where you're exceeding specific state requirements and why; this becomes your evidence of good-faith compliance if enforcement questions arise.
Prevention Checklist
Use this checklist quarterly to catch genetic privacy gaps before they become violations:
- Genetic data inventory is current and includes all business units, acquired companies, and partnership data
- Data classification schema treats genetic information as a distinct category with specific controls
- Consent mechanisms capture state-specific genetic privacy requirements and allow granular user choices
- You've assessed whether your activities meet the DTC genetic testing definition in each state where you operate
- Retention policies for genetic data have documented consumer protection justifications, not just technical rationales
- Customer service escalation procedures flag genetic data complaints for immediate legal review
- You're monitoring state legislatures in your operating jurisdictions for new genetic privacy bills
- Breach response playbooks include genetic data scenarios with AG notification protocols
- Third-party vendors handling genetic data have contractual obligations that meet your highest state standard
- Your compliance documentation explains decisions in terms an Attorney General would understand, not just an auditor
The five states that enacted genetic privacy laws this year won't be the last. Your compliance program needs to absorb new state requirements without a complete rebuild each time. Get the architecture right now, while you still have time to fix mistakes before they become enforcement actions.
